Company Search:
Advanced Search
Sponsored Links
Global Blood Therapeutics Inc Company Snapshot
Global Blood Therapeutics Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Global Blood Therapeutics Inc with three other companies in this sector in UNITED STATES : ProQR Therapeutics NV (2019 sales of $2.16 million ), Synlogic Inc ($2.22 million of which 100% was Discovery and development of synthetic b), and Clearside Biomedical Inc ($2.17 million of which 100% was Pharmaceutical).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Global Blood Therapeutics Inc
  Stock Performance Chart for Global Blood Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (3/27/2020): 51.12
(Figures in U.S. Dollars)
1 Week 13.4%   13 Weeks -20.1%  
4 Weeks -35.4%   52 Weeks -3.4%  
Global Blood Therapeutics Inc Key Data:
  Ticker: GBT Country: United States
  Exchanges: NYSE Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 2,108,000
(Year Ending Jan 2020).
Employees: 352
  Currency: U.S. Dollars Market Cap: 3,100,140,706
  Fiscal Yr Ends: December Shares Outstanding: 60,644,380
  Share Type: Common Closely Held Shares: 7,362,925
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.